(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. Vma2pArch-containing yeast show increased sensitivity
to cycloheximide and wortmannin. VMA2
yeast cells carrying no
plasmid (Null) or transformed with yeast B subunit (WT),
Vma2pPhe (Phe) or Vma2pArch (Arch)
plasmids were grown to log phase, carefully counted so that each type of cell
was at the same starting concentration, subjected to serial 10-fold dilutions,
and then transferred to plates with control media (A) or media containing
sub-lethal doses of various drugs (B) as indicated in Materials and methods
for 3 days. Ct, camptothecin; Hu, hydroxyurea; Cx, cycloheximide; Wt,
wortmannin; Sm, sulfometuron methyl; Fk, FK506.